Apellis Pharmaceuticals Other Current Assets (Quarterly) Analysis

Apellis Pharmaceuticals, Inc. (APLS)

19.94 -0.59 (-2.87%) USD | NASDAQ | Jan 16, 16:00

19.80 -0.14 (-0.70%) Pre-Market: 09:13

View Other Current Assets (Quarterly) for APLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Assets (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Ionis Pharmaceuticals, Inc.	Upgrade
Fortress Biotech, Inc.	Upgrade
Sarepta Therapeutics, Inc.	Upgrade